China Shineway Pharmaceutical Group Limited (HKG: 2877)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
8.34
+0.01 (0.12%)
Nov 15, 2024, 2:36 PM HKT

China Shineway Pharmaceutical Group Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
6,2355,8895,0264,2063,9433,946
Upgrade
Short-Term Investments
-4.023.694.325.3222.76
Upgrade
Trading Asset Securities
-2020.23---
Upgrade
Cash & Short-Term Investments
6,2355,9135,0504,2103,9483,969
Upgrade
Cash Growth
16.22%17.08%19.96%6.63%-0.52%9.67%
Upgrade
Accounts Receivable
1,2991,260975.06825.18760.66674.31
Upgrade
Other Receivables
-63.9267.4840.8723.0722.74
Upgrade
Receivables
1,2991,3241,043866.05783.73697.05
Upgrade
Inventory
830.29897.71657.66587.96443430.8
Upgrade
Other Current Assets
101.0319.9432.0135.06343.99106.43
Upgrade
Total Current Assets
8,4658,1556,7825,6995,5195,203
Upgrade
Property, Plant & Equipment
1,2131,2051,2171,2521,3951,494
Upgrade
Goodwill
165.96165.96165.96165.96102.5159.29
Upgrade
Other Intangible Assets
27.7532.7947.3566.4336.96248.27
Upgrade
Long-Term Deferred Tax Assets
12.415.2319.2220.4723.126.8
Upgrade
Other Long-Term Assets
----137.14-
Upgrade
Total Assets
9,8849,5748,2327,2047,2147,131
Upgrade
Accounts Payable
460.69484.79308.75228.62164.38189.45
Upgrade
Accrued Expenses
13.781,121856.76483.21319.13252.7
Upgrade
Short-Term Debt
330300--369.32398.39
Upgrade
Current Portion of Leases
8.680.976.537.597.794.66
Upgrade
Current Income Taxes Payable
68.3105.91107.7965.158.3739.48
Upgrade
Current Unearned Revenue
121.24127.4165.22117.0578.42100.89
Upgrade
Other Current Liabilities
1,432294.13220.54196.81197.28192.44
Upgrade
Total Current Liabilities
2,4352,4341,6661,0981,1951,178
Upgrade
Long-Term Leases
12.380.360.917.3215.031.49
Upgrade
Long-Term Unearned Revenue
85.4188.89163.99171.59204.31127.92
Upgrade
Long-Term Deferred Tax Liabilities
15.2516.2618.8425.195.347
Upgrade
Total Liabilities
2,5482,5391,8491,3021,4191,354
Upgrade
Common Stock
87.6687.6687.6687.6687.6687.66
Upgrade
Additional Paid-In Capital
422.14422.14422.14422.14422.14422.14
Upgrade
Retained Earnings
7,3227,0206,3685,8795,7785,724
Upgrade
Comprehensive Income & Other
-494.89-494.89-494.89-487.32-493.42-457.11
Upgrade
Total Common Equity
7,3367,0356,3835,9015,7945,777
Upgrade
Shareholders' Equity
7,3367,0356,3835,9015,7945,777
Upgrade
Total Liabilities & Equity
9,8849,5748,2327,2047,2147,131
Upgrade
Total Debt
351.06301.337.4414.91392.14404.54
Upgrade
Net Cash (Debt)
5,8845,6115,0434,1953,5563,564
Upgrade
Net Cash Growth
16.28%11.28%20.20%17.97%-0.23%-1.50%
Upgrade
Net Cash Per Share
7.797.436.685.564.704.56
Upgrade
Filing Date Shares Outstanding
755.4755.4755.4755.4754.6761.63
Upgrade
Total Common Shares Outstanding
755.4755.4755.4755.4754.6761.63
Upgrade
Working Capital
6,0305,7215,1174,6014,3244,025
Upgrade
Book Value Per Share
9.719.318.457.817.687.58
Upgrade
Tangible Book Value
7,1436,8366,1695,6695,6555,369
Upgrade
Tangible Book Value Per Share
9.469.058.177.507.497.05
Upgrade
Machinery
-1,4891,4381,3921,3881,315
Upgrade
Construction In Progress
-117.68193.06130.17115.5118.93
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.